SWKH
SWK Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SWKH
Swk Holdings Corporation
A specialty finance company that provides capital to healthcare and life science companies in the US
5956 Sherry Lane, Suite 650, Dallas, Texas 75225
--
SWK Holdings Corporation was incorporated in California in July 1996 and re-established in Delaware in September 1999. In July 2012, the company started its corporate strategy to build a specialty finance and asset management business. Their strategy is to become a leading healthcare capital provider by providing advanced, tailored financing solutions to a variety of life science companies, institutions and inventors. Their focus is on monetizing the cash flow generated from commercial-stage products and related intellectual property through the purchase and financing of franchise rights, as well as through the creation of synthetic revenue interests in commercialized products.
Earnings Call
Company Financials
EPS
SWKH has released its 2025 Q3 earnings. EPS was reported at 0.6, versus the expected 0.34, beating expectations. The chart below visualizes how SWKH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SWKH has released its 2025 Q3 earnings report, with revenue of 10.88M, reflecting a YoY change of 4.45%, and net profit of 8.78M, showing a YoY change of 153.17%. The Sankey diagram below clearly presents SWKH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


